Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial

PaperCitations, authors & open-access status

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 635 citations, 2018 year and green oa status.

635
Citations
2018
Year
green
OA Status

Related on ScholarIQ

Jason Abbott
Author
Kevin Delucchi
Author
The Lancet Respiratory Medicine
Journal
Mesenchymal stem cell research
Topic
Mesenchymal stem cell research
Topic
Neonatal Respiratory Health Research
Topic
470M+ articles · free account